Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Molecular Evolutionary Analysis of ABCB5: The Ancestral Gene Is a Full Transporter with Potentially Deleterious Single Nucleotide Polymorphisms
  2. Moitra, K.; Scally, M.; McGee, K.; Lancaster, G.; Gold, B.; Dean, M.
  3. Plos One. 2011, Jan; 6(1): 12.
  1. 2.   Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line
  2. Vogel, C.; Abreu, R. D.; Ko, D. J.; Le, S. Y.; Shapiro, B. A.; Burns, S. C.; Sandhu, D.; Boutz, D. R.; Marcotte, E. M.; Penalva, L. O.
  3. Molecular Systems Biology. 2010, Aug; 6: 9.
  1. 3.   Non-AUG translational initiation of a short CAPC transcript generating protein isoform
  2. Anaganti, S.; Hansen, J. K.; Ha, D.; Hahn, Y.; Chertov, O.; Pastan, I.; Bera, T. K.
  3. Biochemical and Biophysical Research Communications. 2009 380(3): 508-513.
  1. 4.   The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA
  2. Keating, C. P.; Hill, M. K.; Hawkes, D. J.; Smyth, R. P.; Isel, C.; Le, S. Y.; Palmenberg, A. C.; Marshall, J. A.; Marquet, R.; Nabel, G. J.; Mak, J.
  3. Nucleic Acids Research. 2009 37(3): 945-956.
  1. 5.   Role of 3'UTRs in the translation of mRNAs regulated by oncogenic eIF4E--a computational inference
  2. Santhanam, A. N.; Bindewald, E.; Rajasekhar, V. K.; Larsson, O.; Sonenberg, N.; Colburn, N. H.; Shapiro, B. A.
  3. Plos One. 2009 4(3):
  1. 6.   Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors
  2. Mechanic, L. E.; Bowman, E. D.; Welsh, J. A.; Khan, M. A.; Hagiwara, N.; Enewold, L.; Shields, P. G.; Burdette, L.; Chanock, S.; Harris, C. C.
  3. Cancer Epidemiology Biomarkers & Prevention. 2007, Feb; 16(2): 214-222.
  1. 7.   Immunogenicity testing of a novel engineered HIV-1 envelope Gp140 DNA vaccine construct
  2. Kumar, S.; Yan, J.; Muthumani, K.; Ramanathan, M. P.; Yoon, H.; Pavlakis, G. N.; Felber, B. K.; Sidhu, M.; Boyer, J. D.; Weiner, D. B.
  3. DNA and Cell Biology. 2006, Jul; 25(7): 383-392.
  1. 8.   CorreLogo: an online server for 3D sequence logos of RNA and DNA alignments
  2. Bindewald, E.; Schneider, T. D.; Shapiro, B. A.
  3. Nucleic Acids Research. 2006, Jul; 34: W405-W411.
  1. 9.   Molecular architecture and ligand recognition determinants for T4 RNA ligase
  2. El Omari, K.; Ren, J.; Bird, L. E.; Bona, M. K.; Klarmann, G.; Legrice, S. F. J.; Stammers, D. K.
  3. Journal of Biological Chemistry. 2006, JAN 20; 281(3): 1573-1579.
  1. 10.   Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail
  2. Wyss, S.; Dimitrov, A. S.; Baribaud, F.; Edwards, T. G.; Blumenthal, R.; Hoxie, J. A.
  3. Journal of Virology. 2005, OCT; 79(19): 12231-12241.
  1. 11.   The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours
  2. Youngren, K. K.; Coveney, D.; Peng, X. N.; Bhattacharya, C.; Schmidt, L. S.; Nickerson, M. L.; Lamb, B. T.; Deng, J. M.; Behringer, R. R.; Capel, B.; Rubin, E. M.; Nadeau, J. H.; Matin, A.
  3. Nature. 2005, MAY 19; 435(7040): 360-364.
  1. 12.   PKC delta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant
  2. Jelacic, T.; Linnekin, D.
  3. Blood. 2005, MAR 1; 105(5): 1923-1929.
  1. 13.   Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma
  2. Huang, W. Y.; Chatterjee, N.; Chanock, S.; Dean, M.; Yeager, M.; Schoen, R. E.; Hou, L. F.; Berndt, S. I.; Yadavalli, S.; Johnson, C. C.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, JAN; 14(1): 152-157.
  1. 14.   Release factors eRF1 and RF2 - A universal mechanism controls the large conformational changes
  2. Ma, B. Y.; Nussinov, R.
  3. Journal of Biological Chemistry. 2004, DEC 17; 279(51): 53875-53885.
  1. 15.   CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women
  2. Yang, X. H. R.; Wacholder, S.; Xu, Z. Y.; Dean, M.; Clark, V.; Gold, B.; Brown, L. M.; Stone, B. J.; Fraumeni, J. F.; Caporaso, N. E.
  3. Cancer Letters. 2004, OCT 28; 214(2): 197-204.
  1. 16.   Effects of the Delta 67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision
  2. Boyer, P. L.; Imamichi, T.; Sarafianos, S. G.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2004, SEP; 78(18): 9987-9997.
  1. 17.   Synthetic tRNA(Lys,3) as the replication primer for the HIV-1(HXB2) and HIV-1(Mal) genomes
  2. Miller, J. T.; Khvorova, A.; Scaringe, S. A.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2004 32(15): 4687-4695.
  1. 18.   Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5 ' untranslated region
  2. Cencig, S.; Nanbru, C.; Le, S. Y.; Gueydan, C.; Huez, G.; Kruys, V.
  3. Oncogene. 2004 23(1): 267-277.
  1. 19.   A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer
  2. Okimoto, K.; Sakurai, J.; Kobayashi, T.; Mitani, H.; Hirayama, Y.; Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.; Hino, O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(7): 2023-2027.
  1. 20.   Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes
  2. Voronin, Y. A.; Pathak, V. K.
  3. Journal of Virology. 2004 78(10): 5402-5413.
  1. 21.   HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallization
  2. Vickrey, J. F.; Logsdon, B. C.; Proteasa, G.; Palmer, S.; Winters, M. A.; Merigan, T. C.; Kovari, L. C.
  3. Protein Expression and Purification. 2003 28(1): 165-172.
  1. 22.   Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision
  2. Boyer, P. L.; Sarafianos, S. G.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2002 76(18): 9143-9151.
  1. 23.   Differences between the mutational consequences of replication of cis- and trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide- deoxyguanosine adducts in M13mp7L2 constructs
  2. Ponten, I.; Kroth, H.; Sayer, J. M.; Dipple, A.; Jerina, D. M.
  3. Chemical Research in Toxicology. 2001 14(6): 720-726.
  1. 24.   Factors determining mutagenic potential for individual cis and trans opened benzo[c]phenanthrene diol epoxide-deoxyadenosine adducts
  2. Ponten, I.; Sayer, J. M.; Pilcher, A. S.; Yagi, H.; Kumar, S.; Jerina, D. M.; Dipple, A.
  3. Biochemistry. 2000 39(14): 4136-4144.
  1. 25.   Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain
  2. Sei, S.; Yang, Q. E.; O'Neill, D.; Yoshimura, K.; Nagashima, K.; Mitsuya, H.
  3. Journal of Virology. 2000 74(10): 4621-4633.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel